Inspire Medical Systems, Inc.
INSP
$42.23
-$0.05-0.12%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -23.97% | 19.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.97% | 19.86% | |||
| Cost of Revenue | -23.29% | 13.53% | |||
| Gross Profit | -24.07% | 20.90% | |||
| SG&A Expenses | -6.02% | 1.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.74% | 3.77% | |||
| Operating Income | -102.42% | 378.13% | |||
| Income Before Tax | -95.24% | 271.33% | |||
| Income Tax Expenses | 115.96% | -2,470.02% | |||
| Earnings from Continuing Operations | -108.30% | 1,270.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -108.30% | 1,270.22% | |||
| EBIT | -102.42% | 378.13% | |||
| EBITDA | -92.01% | 274.84% | |||
| EPS Basic | -108.37% | 1,288.66% | |||
| Normalized Basic EPS | -94.78% | 166.52% | |||
| EPS Diluted | -108.44% | 1,277.02% | |||
| Normalized Diluted EPS | -94.73% | 166.36% | |||
| Average Basic Shares Outstanding | -0.84% | -1.33% | |||
| Average Diluted Shares Outstanding | -1.77% | -1.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||